Literature DB >> 12077017

Neurodegeneration in the age of molecular biology.

Lawrence I Golbe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12077017      PMCID： PMC1123427          DOI： 10.1136/bmj.324.7352.1467

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  The tau A0 allele in Parkinson's disease.

Authors:  L I Golbe; A M Lazzarini; J R Spychala; W G Johnson; E S Stenroos; M H Mark; J I Sage
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

2.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

5.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

7.  A large kindred with autosomal dominant Parkinson's disease.

Authors:  L I Golbe; G Di Iorio; V Bonavita; D C Miller; R C Duvoisin
Journal:  Ann Neurol       Date:  1990-03       Impact factor: 10.422

8.  Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2002-04-09       Impact factor: 3.162

9.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

10.  Widespread alterations of alpha-synuclein in multiple system atrophy.

Authors:  D W Dickson; W Liu; J Hardy; M Farrer; N Mehta; R Uitti; M Mark; T Zimmerman; L Golbe; J Sage; A Sima; C D'Amato; R Albin; S Gilman; S H Yen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307
View more
  1 in total

1.  Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.

Authors:  Rosaria Giordano; Margherita Canesi; Maurizio Isalberti; Ioannis Ugo Isaias; Tiziana Montemurro; Mariele Viganò; Elisa Montelatici; Valentina Boldrin; Riccardo Benti; Agostino Cortelezzi; Nicola Fracchiolla; Lorenza Lazzari; Gianni Pezzoli
Journal:  J Transl Med       Date:  2014-01-17       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.